Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Debopam Samanta

Concepts (327)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Epilepsy
28
2024
177
13.070
 Why?
Seizures
22
2024
197
5.700
 Why?
Anticonvulsants
14
2024
123
5.550
 Why?
Tuberous Sclerosis
7
2024
38
4.360
 Why?
Cannabidiol
7
2024
39
4.050
 Why?
Spasms, Infantile
9
2024
27
4.020
 Why?
Status Epilepticus
6
2021
40
3.470
 Why?
Epilepsies, Myoclonic
5
2024
12
3.280
 Why?
Mutation
16
2023
1296
3.220
 Why?
Humans
108
2024
50251
2.550
 Why?
Electroencephalography
17
2022
307
2.440
 Why?
Intellectual Disability
5
2023
124
2.300
 Why?
Brain
10
2024
1319
2.240
 Why?
Hemiplegia
3
2021
11
2.130
 Why?
Child
38
2024
6854
2.090
 Why?
Deep Brain Stimulation
3
2024
42
2.060
 Why?
Developmental Disabilities
5
2019
119
1.780
 Why?
Epilepsy, Absence
3
2019
11
1.730
 Why?
Magnetic Resonance Imaging
15
2019
1542
1.660
 Why?
Tumor Suppressor Proteins
3
2023
128
1.480
 Why?
Neuroaxonal Dystrophies
2
2022
8
1.470
 Why?
Nervous System Malformations
3
2020
17
1.460
 Why?
Folate Receptor 1
2
2022
25
1.440
 Why?
Infant
20
2024
3560
1.430
 Why?
Epilepsies, Partial
2
2022
12
1.350
 Why?
Infant, Newborn, Diseases
2
2020
57
1.350
 Why?
Ketamine
2
2020
60
1.330
 Why?
Neurocutaneous Syndromes
2
2019
6
1.210
 Why?
Child, Preschool
19
2024
3877
1.200
 Why?
Cadherins
2
2019
68
1.180
 Why?
Cerebral Arteries
2
2019
40
1.110
 Why?
Epilepsy, Generalized
2
2023
8
1.090
 Why?
Vigabatrin
3
2024
3
1.080
 Why?
Sirolimus
2
2017
62
1.070
 Why?
Angiofibroma
2
2015
5
1.040
 Why?
Facial Neoplasms
2
2015
22
1.020
 Why?
Nerve Tissue Proteins
2
2018
194
1.010
 Why?
Valproic Acid
2
2022
32
1.000
 Why?
Randomized Controlled Trials as Topic
2
2024
544
0.960
 Why?
Stroke
3
2019
482
0.960
 Why?
Fenfluramine
2
2024
8
0.950
 Why?
Dioxolanes
2
2024
13
0.940
 Why?
Thalamus
1
2024
36
0.940
 Why?
Male
33
2024
25483
0.920
 Why?
Pregnanolone
2
2023
6
0.910
 Why?
Female
29
2024
26668
0.900
 Why?
Landau-Kleffner Syndrome
1
2022
3
0.860
 Why?
Treatment Outcome
10
2024
5186
0.830
 Why?
Quality Improvement
2
2022
209
0.830
 Why?
Aphasia
1
2022
32
0.810
 Why?
Nervous System Diseases
2
2021
89
0.800
 Why?
Chromosome Deletion
3
2019
140
0.780
 Why?
Abnormalities, Multiple
3
2023
167
0.780
 Why?
Emergencies
1
2021
86
0.750
 Why?
Algorithms
1
2024
618
0.740
 Why?
Pharmaceutical Preparations
1
2021
79
0.740
 Why?
Angelman Syndrome
1
2020
1
0.740
 Why?
Transition to Adult Care
1
2020
17
0.730
 Why?
Immunoglobulins, Intravenous
1
2021
54
0.720
 Why?
Bone Diseases, Developmental
2
2023
14
0.720
 Why?
Tooth Abnormalities
2
2023
12
0.710
 Why?
Oligonucleotides, Antisense
1
2020
28
0.700
 Why?
Phenobarbital
1
2020
17
0.700
 Why?
Behavioral Symptoms
1
2019
2
0.700
 Why?
Flunarizine
1
2019
1
0.690
 Why?
Immunologic Factors
1
2021
114
0.690
 Why?
Excitatory Amino Acid Antagonists
1
2020
50
0.690
 Why?
Ocular Physiological Phenomena
1
2019
4
0.680
 Why?
Tetrasomy
1
2019
2
0.680
 Why?
Agenesis of Corpus Callosum
2
2018
10
0.680
 Why?
Chromosomes, Human, Pair 5
1
2019
17
0.670
 Why?
Sneddon Syndrome
1
2019
3
0.670
 Why?
Livedo Reticularis
1
2019
5
0.670
 Why?
Oral Ulcer
1
2019
3
0.670
 Why?
Behcet Syndrome
1
2019
7
0.660
 Why?
Calcium Channel Blockers
1
2019
63
0.660
 Why?
Transposases
1
2019
10
0.660
 Why?
Andersen Syndrome
1
2019
1
0.660
 Why?
Spinal Cord Diseases
1
2019
37
0.650
 Why?
Hydrocephalus
1
2019
43
0.650
 Why?
Receptors, GABA-B
1
2019
11
0.650
 Why?
Genetic Therapy
1
2020
115
0.650
 Why?
Vitiligo
1
2019
8
0.650
 Why?
Nephrotic Syndrome
2
2017
18
0.650
 Why?
Leukoencephalopathies
1
2019
14
0.650
 Why?
Autoimmune Diseases of the Nervous System
1
2019
9
0.650
 Why?
Cytochrome-c Oxidase Deficiency
1
2018
3
0.650
 Why?
Migraine Disorders
2
2020
46
0.640
 Why?
Edema
1
2019
69
0.640
 Why?
Electron Transport Complex IV
1
2018
29
0.640
 Why?
Cannabinoid Receptor Agonists
1
2019
49
0.640
 Why?
Cerebral Infarction
1
2018
39
0.640
 Why?
Muscle Weakness
1
2019
44
0.630
 Why?
Physicians
1
2022
227
0.630
 Why?
Diffuse Cerebral Sclerosis of Schilder
1
2018
8
0.630
 Why?
Amino Acyl-tRNA Synthetases
1
2018
6
0.630
 Why?
Shab Potassium Channels
1
2018
2
0.630
 Why?
Optic Atrophy
1
2018
17
0.630
 Why?
Photic Stimulation
1
2018
60
0.630
 Why?
Alopecia
1
2019
39
0.630
 Why?
Parents
1
2021
314
0.620
 Why?
Brain Edema
1
2018
41
0.620
 Why?
Lymphohistiocytosis, Hemophagocytic
1
2018
26
0.610
 Why?
Thrombocytopenia
1
2019
83
0.610
 Why?
Myoclonus
1
2018
9
0.610
 Why?
Artifacts
1
2018
54
0.610
 Why?
Biomedical Research
1
2021
237
0.610
 Why?
Mitochondrial Diseases
1
2018
42
0.600
 Why?
Autoimmune Diseases
1
2019
101
0.600
 Why?
Practice Guidelines as Topic
1
2020
452
0.590
 Why?
Neurodegenerative Diseases
1
2018
76
0.590
 Why?
Hearing Loss, Sensorineural
1
2018
75
0.580
 Why?
Osteochondrodysplasias
1
2017
13
0.570
 Why?
Immunologic Deficiency Syndromes
1
2017
19
0.570
 Why?
Health Knowledge, Attitudes, Practice
1
2021
486
0.570
 Why?
Adolescent
13
2024
6402
0.570
 Why?
Phenotype
2
2021
732
0.570
 Why?
Arteriosclerosis
1
2017
54
0.570
 Why?
Carotid Artery Diseases
1
2017
32
0.560
 Why?
Models, Biological
1
2020
726
0.560
 Why?
Infant, Newborn
6
2024
2767
0.560
 Why?
Drug Discovery
1
2017
88
0.560
 Why?
Child Development
1
2018
191
0.550
 Why?
Prenatal Exposure Delayed Effects
1
2018
183
0.550
 Why?
Cafe-au-Lait Spots
1
2016
2
0.540
 Why?
Erythema Infectiosum
1
2015
3
0.530
 Why?
Migraine with Aura
1
2015
4
0.530
 Why?
Williams Syndrome
1
2016
26
0.530
 Why?
Leukoencephalitis, Acute Hemorrhagic
1
2015
3
0.530
 Why?
Corpus Callosum
2
2023
28
0.530
 Why?
Skin
1
2019
415
0.530
 Why?
Syndrome
6
2024
239
0.530
 Why?
Sinus Pericranii
1
2015
1
0.530
 Why?
Parvovirus B19, Human
1
2015
17
0.520
 Why?
Pulmonary Embolism
1
2017
97
0.520
 Why?
Toes
1
2015
14
0.520
 Why?
SOS1 Protein
1
2015
2
0.520
 Why?
Electrodiagnosis
1
2015
12
0.520
 Why?
Crying
1
2015
4
0.520
 Why?
Moyamoya Disease
1
2015
7
0.520
 Why?
Hyperventilation
1
2015
8
0.520
 Why?
Tuberculoma
1
2015
2
0.510
 Why?
Iatrogenic Disease
1
2015
24
0.510
 Why?
Epilepsy, Benign Neonatal
1
2015
2
0.510
 Why?
Noonan Syndrome
1
2015
12
0.510
 Why?
Neurologic Examination
1
2015
77
0.510
 Why?
Encephalitis
1
2016
41
0.510
 Why?
Communication
3
2022
246
0.500
 Why?
Mutism
1
2015
3
0.500
 Why?
NAV1.2 Voltage-Gated Sodium Channel
1
2015
3
0.500
 Why?
Ocular Motility Disorders
1
2015
17
0.500
 Why?
TOR Serine-Threonine Kinases
1
2015
77
0.500
 Why?
Repressor Proteins
2
2023
153
0.500
 Why?
Diagnosis, Differential
7
2020
1043
0.490
 Why?
Trisomy
1
2014
31
0.490
 Why?
Influenza, Human
1
2015
82
0.480
 Why?
Neurology
1
2015
35
0.480
 Why?
KCNQ2 Potassium Channel
1
2014
9
0.480
 Why?
Energy Drinks
1
2014
6
0.480
 Why?
Vasoconstriction
1
2014
55
0.470
 Why?
Benzodiazepines
1
2014
73
0.470
 Why?
Osteomyelitis
1
2015
125
0.470
 Why?
Membrane Proteins
1
2016
353
0.450
 Why?
Sleep
1
2014
183
0.440
 Why?
Enzyme Inhibitors
1
2015
387
0.430
 Why?
Magnetic Resonance Angiography
3
2019
76
0.420
 Why?
Immunosuppressive Agents
3
2019
223
0.410
 Why?
Pediatrics
1
2015
275
0.400
 Why?
Quality of Life
3
2022
837
0.380
 Why?
Receptors, N-Methyl-D-Aspartate
2
2022
127
0.360
 Why?
Diffusion Magnetic Resonance Imaging
3
2017
124
0.360
 Why?
Clinical Trials as Topic
2
2024
466
0.350
 Why?
Caregivers
2
2021
211
0.330
 Why?
Recurrence
3
2019
661
0.320
 Why?
Echinocandins
1
2008
64
0.310
 Why?
Mycoses
1
2008
157
0.290
 Why?
Gastroesophageal Reflux
2
2019
50
0.280
 Why?
Antifungal Agents
1
2008
341
0.260
 Why?
Administration, Topical
2
2015
56
0.260
 Why?
Retrospective Studies
6
2023
6172
0.250
 Why?
Seizures, Febrile
1
2024
2
0.250
 Why?
Meta-Analysis as Topic
1
2024
38
0.240
 Why?
Intralaminar Thalamic Nuclei
1
2024
6
0.230
 Why?
Adult
5
2024
13384
0.230
 Why?
Psychosurgery
1
2023
5
0.230
 Why?
Databases, Factual
2
2024
655
0.230
 Why?
Laser Therapy
1
2023
84
0.220
 Why?
Speech Disorders
1
2022
15
0.210
 Why?
Ethosuximide
1
2022
5
0.210
 Why?
Clonazepam
1
2022
5
0.210
 Why?
Electrodes, Implanted
1
2022
30
0.210
 Why?
Stereotaxic Techniques
1
2022
37
0.210
 Why?
Cluster Analysis
1
2023
235
0.210
 Why?
Death, Sudden
1
2022
10
0.200
 Why?
GTPase-Activating Proteins
1
2022
23
0.200
 Why?
Review Literature as Topic
1
2022
18
0.200
 Why?
Palliative Care
1
2024
186
0.200
 Why?
Concept Formation
1
2021
12
0.200
 Why?
Perivascular Epithelioid Cell Neoplasms
1
2021
4
0.200
 Why?
Freedom
1
2021
3
0.200
 Why?
Diazepam
1
2021
17
0.190
 Why?
Folic Acid
1
2022
137
0.190
 Why?
Drug Interactions
1
2022
209
0.190
 Why?
Fibroma
1
2021
39
0.190
 Why?
Risk Factors
2
2020
3608
0.190
 Why?
Adrenocorticotropic Hormone
2
2022
31
0.190
 Why?
Personal Satisfaction
1
2021
75
0.190
 Why?
Soft Tissue Neoplasms
1
2021
56
0.190
 Why?
Brain Diseases
1
2021
81
0.180
 Why?
Dihydroergotamine
1
2020
4
0.180
 Why?
Perception
1
2021
115
0.180
 Why?
Facies
2
2023
35
0.180
 Why?
Transcription Factors
2
2023
564
0.180
 Why?
Diet Therapy
1
2020
8
0.180
 Why?
Genetic Diseases, Inborn
1
2020
23
0.180
 Why?
Consensus
1
2021
154
0.170
 Why?
Clinical Protocols
1
2020
108
0.170
 Why?
Treatment Failure
1
2020
116
0.170
 Why?
Ubiquitin-Protein Ligases
1
2020
96
0.170
 Why?
Anesthetics
1
2020
36
0.170
 Why?
Leukomalacia, Periventricular
1
2019
12
0.170
 Why?
Muscle Hypotonia
1
2019
21
0.170
 Why?
Chromosomes, Human, Pair 7
1
2019
29
0.170
 Why?
Matrix Attachment Region Binding Proteins
1
2020
35
0.170
 Why?
Learning
1
2021
158
0.170
 Why?
HLA-B51 Antigen
1
2019
2
0.170
 Why?
Patient-Centered Care
1
2021
129
0.170
 Why?
Qualitative Research
1
2021
339
0.170
 Why?
Craniofacial Abnormalities
1
2019
27
0.170
 Why?
Ventriculoperitoneal Shunt
1
2019
26
0.170
 Why?
Analgesics, Non-Narcotic
1
2020
117
0.170
 Why?
Heart Septal Defects, Atrial
1
2019
44
0.160
 Why?
Potassium Channels, Inwardly Rectifying
1
2019
7
0.160
 Why?
Ventricular Premature Complexes
1
2019
7
0.160
 Why?
Disease Management
1
2020
176
0.160
 Why?
Microcephaly
1
2019
41
0.160
 Why?
Melkersson-Rosenthal Syndrome
1
2018
4
0.160
 Why?
Facial Nerve Diseases
1
2018
6
0.160
 Why?
Referral and Consultation
1
2021
285
0.160
 Why?
Syncope
1
2019
28
0.160
 Why?
Nocturnal Myoclonus Syndrome
1
2018
13
0.160
 Why?
Cerebral Veins
1
2018
15
0.160
 Why?
Facial Paralysis
1
2018
24
0.160
 Why?
Anti-Arrhythmia Agents
1
2019
81
0.160
 Why?
Deglutition Disorders
1
2019
77
0.160
 Why?
Acute Disease
1
2019
368
0.160
 Why?
Health Personnel
1
2021
254
0.150
 Why?
Fatal Outcome
1
2019
196
0.150
 Why?
Video Recording
1
2018
80
0.150
 Why?
Frameshift Mutation
1
2018
17
0.150
 Why?
Fibrinolytic Agents
1
2019
125
0.150
 Why?
Combined Modality Therapy
1
2020
641
0.150
 Why?
Anti-Inflammatory Agents
1
2019
161
0.150
 Why?
Fear
1
2018
83
0.150
 Why?
India
1
2017
51
0.150
 Why?
Platelet Aggregation Inhibitors
1
2019
173
0.150
 Why?
History, 21st Century
1
2017
56
0.150
 Why?
Cerebellum
1
2018
134
0.150
 Why?
History, 20th Century
1
2017
95
0.140
 Why?
Neurotoxicity Syndromes
1
2017
46
0.140
 Why?
Methotrexate
1
2017
71
0.140
 Why?
Anti-Infective Agents
1
2017
95
0.140
 Why?
Pandemics
1
2021
567
0.140
 Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2017
92
0.140
 Why?
Animals
3
2022
13285
0.140
 Why?
Aldehyde Dehydrogenase
1
2016
26
0.130
 Why?
Hormones
1
2016
57
0.130
 Why?
Influenza B virus
1
2015
6
0.130
 Why?
Delayed Diagnosis
1
2016
23
0.130
 Why?
Chromosomes, Human, Pair 3
1
2015
19
0.130
 Why?
Arkansas
1
2021
1962
0.130
 Why?
North America
1
2015
65
0.130
 Why?
Cerebral Angiography
1
2015
97
0.120
 Why?
Antibiotics, Antineoplastic
1
2015
80
0.120
 Why?
Chromosomes, Human, Pair 9
1
2014
19
0.120
 Why?
Complementary Therapies
1
2015
25
0.120
 Why?
Brain Waves
1
2014
19
0.120
 Why?
Drug Resistance
1
2015
64
0.120
 Why?
Antiemetics
1
2014
32
0.120
 Why?
Polymerase Chain Reaction
1
2015
455
0.120
 Why?
Headache
1
2014
76
0.120
 Why?
Vomiting
1
2014
75
0.110
 Why?
Glutamine
1
2015
171
0.110
 Why?
Mutation, Missense
1
2014
106
0.110
 Why?
Arginine
1
2015
179
0.110
 Why?
Analgesics
1
2014
101
0.110
 Why?
Decision Making, Computer-Assisted
1
2013
4
0.110
 Why?
Diagnostic Errors
1
2013
63
0.110
 Why?
Evidence-Based Medicine
1
2013
247
0.100
 Why?
Inflammation
1
2016
607
0.100
 Why?
Pregnancy
1
2018
2605
0.090
 Why?
Signal Transduction
1
2017
1624
0.090
 Why?
Dysentery
1
2009
1
0.080
 Why?
Trichuriasis
1
2009
1
0.080
 Why?
Trichuris
1
2009
1
0.080
 Why?
Antineoplastic Agents
1
2017
1186
0.080
 Why?
Anesthesia, Intravenous
1
2008
13
0.080
 Why?
Eosinophils
1
2009
45
0.080
 Why?
Lipopeptides
1
2008
63
0.080
 Why?
Amyloidosis
1
2009
79
0.080
 Why?
Inflammatory Bowel Diseases
1
2009
51
0.080
 Why?
Tuberculosis
1
2009
147
0.080
 Why?
Candidiasis
1
2008
114
0.080
 Why?
Aspergillosis
1
2008
125
0.070
 Why?
Kidney Diseases
1
2009
213
0.070
 Why?
Prospective Studies
2
2023
2379
0.070
 Why?
Spasm
1
2024
9
0.060
 Why?
Feedback
1
2024
52
0.060
 Why?
Probability
1
2023
163
0.060
 Why?
Neuroimaging
1
2023
85
0.050
 Why?
Neurosurgical Procedures
1
2024
122
0.050
 Why?
Potassium Channels
1
2021
32
0.050
 Why?
Registries
1
2024
513
0.050
 Why?
Administration, Intravenous
1
2020
69
0.040
 Why?
Sleep Stages
1
2020
45
0.040
 Why?
Cognition
1
2022
312
0.040
 Why?
Age of Onset
1
2020
106
0.040
 Why?
Immunohistochemistry
1
2021
978
0.040
 Why?
Software
1
2013
273
0.020
 Why?
Internet
1
2013
258
0.020
 Why?
Young Adult
1
2020
4002
0.020
 Why?
Mebendazole
1
2009
2
0.020
 Why?
Antinematodal Agents
1
2009
3
0.020
 Why?
Leukemoid Reaction
1
2009
6
0.020
 Why?
Antitubercular Agents
1
2009
106
0.020
 Why?
Colonoscopy
1
2009
94
0.020
 Why?
Prognosis
1
2009
1959
0.010
 Why?
Samanta's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (327) concept(s)
_
Co-Authors Expand Description
See all (13) people
_
Similar People Expand Description
See all (32) people
_
Same Department Expand Description
Search Department